MedTrace Logo

Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)

NCT01874327 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2018-10-10

No results posted yet for this study

Summary

The study will evaluate the efficacy of a novel intervention implemented in a classroom setting aimed at improving joint attention and joint engagement skills with infants who are at risk of developing an Autism Spectrum Disorder.

Conditions

  • Children at Risk for ASD

Interventions

BEHAVIORAL

Baby JASPER

Intervention focuses on core deficits of joint attention, play, engagement, and regulation embedded within AEPS curriculum

BEHAVIORAL

Standard Baby Classroom

Assessment, Education and Programming System (AEPS) for Infants and Children curriculum focused on early developmental milestones in fine and gross motor, cognitive, adaptive and social areas

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
21 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2018-08-31
Completion
2018-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01874327 on ClinicalTrials.gov